Search

Your search keyword '"Ojeda Pineda S"' showing total 22 results
Start Over Author "Ojeda Pineda S"
22 results on '"Ojeda Pineda S"'

2. Role of three-dimensional imaging techniques in the management of transcatheter closure of complex atrial septal defects

Author

Pastor- Wulf, D, primary, Rodriguez Almodovar, A, additional, Rodriguez Nieto, J, additional, Ruiz Ortiz, M, additional, Perea, J, additional, Delgado Ortega, M, additional, Piserra, A, additional, Esteban Martinez, F, additional, Lopez Baizan, J, additional, Ojeda Pineda, S, additional, Gallo, I, additional, Romero Moreno, M, additional, Suarez De Lezo, J, additional, Pan Alvarez Ossorio, M, additional, and Mesa Rubio, D, additional

Published
2022
Full Text
View/download PDF

3. Long term follow up of elderly patients treated with self-expanding transcatheter aortic valve implantation; a single center experience

Author

Rodriguez Nieto, J, primary, Delgado Ortega, M, additional, Ruiz Ortiz, M, additional, Mesa Rubio, M D, additional, Perea Armijo, J, additional, Piserra Lopez Fernandez De Heredia, A, additional, Rodriguez Almodovar, A, additional, Esteban Martinez, F, additional, Romo Penas, E, additional, Suarez De Lezo, J, additional, Ojeda Pineda, S, additional, Romero Moreno, M A, additional, and Pan Alvarez Ossorio, M, additional

Published
2021
Full Text
View/download PDF

4. Poster Session: Right ventricular systolic function

Author

Morenate Navio, MC, Mesa Rubio, MD, Ortega, M Delgado, Ruiz Ortiz, M, Castillo Bernal, F, Del Pino, C Leon, Toledano, F, Alvarez-Ossorio, M Pan, Ojeda Pineda, S, and Lezo Cruz-Conde, J Suarez De

Published
2012

5. P337 Edge-to-edge mitral valve repair in patients with secondary mitral regurgitation: impact of tethering pattern on clinical, echocardiographic and procedure-related characteristics

Author

Oneto Fernandez, M J, primary, Ruiz Ortiz, M, additional, Delgado Ortega, M, additional, Rodriguez Almodovar, A M, additional, Gonzalez Manzanares, R, additional, Pericet Rodriguez, C, additional, Fernandez Ruiz, A, additional, Luque Moreno, A, additional, Paredes Hurtado, N I, additional, Romero Moreno, M A, additional, Ojeda Pineda, S, additional, Suarez De Lezo Herreros De Tejada, J, additional, Lopez Granados, A J, additional, Pan Alvarez-Ossorio, M, additional, and Mesa Rubio, D, additional

Published
2020
Full Text
View/download PDF

6. 65Effect of atrial fibrillation in the long-term follow-up of patients with severe aortic stenosis treated with the CoreValve prosthesis

Author

Lopez Aguilera, J., primary, Segura Saint-Gerons, J.M., additional, Sanchez Fernandez, J.J., additional, Mazuelos Bellido, F., additional, Suarez De Lezo Herreros De Tejada, J., additional, Ojeda Pineda, S., additional, Romero Moreno, M., additional, Mesa Rubio, D., additional, Pavlovic, D.J., additional, Pardo, L., additional, Rodriguez Diego, S., additional, Ferreiro, C., additional, Chavarria, J., additional, Suarez De Lezo Cruz Conde, J., additional, and Pan Alvarez-Ossorio, M., additional

Published
2017
Full Text
View/download PDF

7. Long-term clinical impact of permanent cardiac pacing after transcatheter aortic valve implantation with the CoreValve prosthesis: a single center experience

Author

López-Aguilera, J, primary, Segura Saint-Gerons, J M, additional, Sánchez Fernández, J, additional, Mazuelos Bellido, F, additional, Pan Álvarez-Ossorio, M, additional, Suárez de Lezo, J, additional, Romero Moreno, M, additional, Ojeda Pineda, S, additional, Pavlovic, D, additional, Mesa Rubio, D, additional, Rodriguez Diego, S, additional, Ferreiro, C, additional, Durán, E, additional, Chavarría, J, additional, and Moya González, J, additional

Published
2017
Full Text
View/download PDF

8. Tratamiento médico de la insuficiencia cardiaca por disfunción diastólica

Author

Ojeda Pineda S and Anguita Sánchez M

Subjects
medicine.medical_specialty, Ejection fraction, Medical treatment, business.industry, Diastolic heart failure, medicine.disease, Clinical trial, Candesartan, Therapeutic approach, Heart failure, Internal medicine, Heart rate, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

Diastolic heart failure (i.e., heart failure with preserved systolic function) accounts for 30%-50% of all cases of heart failure. Prognosis is almost as poor as with systolic heart failure. Currently, the only requirements for diagnosis are that strict clinical criteria for heart failure are satisfied and that the left ventricular ejection fraction is preserved (i.e., greater than 40%-50%), although in the future measurement of brain natriuretic peptides could be useful. Because of a lack of evidence from large clinical trials, with the exception of the CHARM study which showed that candesartan slightly reduced the hospital readmission rate, therapy is based on the identification and treatment of the causal condition (e.g., hypertension or coronary heart disease), heart rate control, and relief of congestion. Thus, combination treatment with low-dose diuretics, bradycardiac antihypertensives (e.g., beta-blockers or calcium antagonists), and angiotensin antagonists currently seems to be the best therapeutic approach.

Published
2006
Full Text
View/download PDF

10. Poster Session: Right ventricular systolic function

Author

Altman, M., primary, Bergerot, C., additional, Thibault, H., additional, Aussoleil, A., additional, Skuldadt Davidsen, E., additional, Barthelet, M., additional, Derumeaux, G. A., additional, Grapsa, J., additional, Zimbarra Cabrita, I., additional, Afilalo, J., additional, Paschou, S., additional, Dawson, D., additional, Durighel, G., additional, O'regan, D., additional, Howard, L., additional, Gibbs, J., additional, Nihoyannopoulos, P., additional, Morenate Navio, M., additional, Mesa Rubio, M., additional, Ortega, M. D., additional, Ruiz Ortiz, M., additional, Castillo Bernal, F., additional, Del Pino, C. L., additional, Toledano, F., additional, Alvarez-Ossorio, M. P., additional, Ojeda Pineda, S., additional, Lezo Cruz-Conde, J. S. D., additional, Jasaityte, R., additional, Claus, P., additional, Teske, A., additional, Herbots, L., additional, Verheyden, B., additional, Rademakers, F., additional, D'hooge, J., additional, Tocchetti, C. G., additional, Coppola, C., additional, Rea, D., additional, Quintavalle, C., additional, Guarino, L., additional, Castaldo, N., additional, De Lorenzo, C., additional, Condorelli, G., additional, Arra, C., additional, Maurea, N., additional, Voilliot, D., additional, Huttin, O., additional, Camara, Y., additional, Djaballah, W., additional, Carillo, S., additional, Zinzius, P., additional, Sellal, J., additional, Angioi, M., additional, Juilliere, Y., additional, Selton-Suty, C., additional, Dobrowolski, P., additional, Klisiewicz, A., additional, Florczak, E., additional, Prejbisz, A., additional, Szwench, E., additional, Rybicka, J., additional, Januszewicz, A., additional, Hoffman, P., additional, Jurado Roman, A., additional, De Dios Perez, S., additional, De Nicolas, J. M. M., additional, Diaz Anton, B., additional, Rubio Alonso, B., additional, Martin Asenjo, R., additional, Mayordomo Gomez, S., additional, Villagraz Tecedor, L., additional, Blazquez, L., additional, De Meneses, R. T., additional, Bernard, A., additional, Hernandez, A. I., additional, Reynaud, A., additional, Lerclercq, C., additional, Daubert, J., additional, Donal, E., additional, Arjan Singh, R., additional, Sivarani, S., additional, Lim, S., additional, Azman, W., additional, Almeida, M., additional, Cardim, N., additional, Fonseca, V., additional, Carmelo, V., additional, Santos, S., additional, Santos, T., additional, Toste, J., additional, Kosmala, W., additional, Orda, A., additional, Karolko, B., additional, Mysiak, A., additional, Przewlocka-Kosmala, M., additional, Farsalinos, K., additional, Tsiapras, D., additional, Kyrzopoulos, S., additional, Avramidou, E., additional, Vassilopoulou, D., additional, Voudris, V., additional, Hayrapetyan, H., additional, Adamyan, K., additional, Montero Cabezas, J., additional, Granda Nistal, C., additional, Garcia Aranda, B., additional, Sanchez Sanchez, V., additional, Sestito, A., additional, Lamendola, P., additional, Di Franco, A., additional, Lauria, C., additional, Lanza, G., additional, Kukucka, M., additional, Unbehaun, A., additional, Buz, S., additional, Mladenow, A., additional, Kuppe, H., additional, Pasic, M., additional, Habazettl, H., additional, Gemma, D., additional, Montoro Lopez, N., additional, De Celix, M. G. R., additional, Lopez Fernandez, T., additional, De Torres Alba, F., additional, Del Valle, D. I., additional, Ramirez, U., additional, Mesa, J., additional, Moreno Yanguela, M., additional, Lopez Sendon, J., additional, Eveborn, G. W., additional, Schirmer, H., additional, Lunde, P., additional, Heggelund, G., additional, Rasmussen, K., additional, Wang, Z., additional, Lasota, B., additional, Mizia-Stec, K., additional, Mizia, M., additional, Chmiel, A., additional, Adamczyk, T., additional, Chudek, J., additional, Gasior, Z., additional, Venkatesh, A., additional, Johnson, J., additional, Sahlen, A., additional, Brodin, L., additional, Winter, R., additional, Shahgaldi, K., additional, Manouras, A., additional, Valbuena, S., additional, Iniesta, A., additional, Lopez, T., additional, De Torres, F., additional, Salinas, P., additional, Garcia, S., additional, Moreno, M., additional, Lopez-Sendon, J., additional, Lebid, I., additional, Kobets, T., additional, Kuzmenko, T., additional, Katsanos, S., additional, Yiu, K., additional, Clavel, M., additional, Nina Ajmone, N., additional, Van Der Kley, F., additional, Rodes Cabau, J., additional, Schalij, M., additional, Bax, J., additional, Pibarot, P., additional, Delgado, V., additional, Fusini, L., additional, Tamborini, G., additional, Muratori, M., additional, Gripari, P., additional, Marsan, N., additional, Cefalu', C., additional, Ewe, S., additional, Maffessanti, F., additional, Pepi, M., additional, Hasselberg, N., additional, Haugaa, K., additional, Petri, H., additional, Berge, K., additional, Leren, T., additional, Bundgaard, H., additional, Edvardsen, T., additional, Ancona, R., additional, Comenale Pinto, S., additional, Caso, P., additional, Coppola, M., additional, Rapisarda, O., additional, Cavallaro, C., additional, Vecchione, F., additional, D'onofrio, A., additional, Calabro', R., additional, Rimbas, R., additional, Mihaila, S., additional, Enescu, O., additional, Patrascu, N., additional, Dragoi, R., additional, Rimbas, M., additional, Pop, C., additional, Vinereanu, D., additional, Gustafsson, S., additional, Morner, S., additional, Gronlund, C., additional, Suhr, O., additional, Lindqvist, P., additional, Di Bella, G., additional, Zito, C., additional, Minutoli, F., additional, Madaffari, A., additional, Cusma Piccione, M., additional, Mazzeo, A., additional, Massimo, R., additional, Pasquale, M., additional, Vita, G., additional, Carerj, S., additional, Rangel, I., additional, Goncalves, A., additional, Sousa, C., additional, Correia, A., additional, Martins, E., additional, Silva-Cardoso, J., additional, Macedo, F., additional, Maciel, M., additional, Pfeiffer, B., additional, Rigopoulos, A., additional, Seggewiss, H., additional, Alvarez Fuente, M., additional, Sainz Costa, T., additional, Medrano, C., additional, Navarro, M., additional, Blazquez Gamero, D., additional, Ramos, J., additional, Mellado, M., additional, De Jose, M., additional, Munoz, M., additional, Maroto, E., additional, Gargani, L., additional, Gosciniak, P., additional, Pratali, L., additional, Agoston, G., additional, Bruni, C., additional, Guiducci, S., additional, Matucci Cerinic, M., additional, Varga, A., additional, Sicari, R., additional, Picano, E., additional, Zhao, C., additional, Mei, M., additional, Yeung, C., additional, Siu, C., additional, Tse, H., additional, Florescu, M., additional, Magda, L., additional, Mincu, R., additional, Daha, I., additional, Stanescu, C. M., additional, Chirila, L., additional, Baicus, C., additional, Vlase, A., additional, Dan, G., additional, Montoro Lopez, M., additional, Florez Gomez, R., additional, Alonso Ladreda, A., additional, Itziar Soto, C., additional, Rios Blanco, J., additional, Guzman Martinez, G., additional, Lichodziejewska, B., additional, Kurnicka, K., additional, Goliszek, S., additional, Kostrubiec, M., additional, Dzikowska-Diduch, O., additional, Ciurzynski, M., additional, Labyk, A., additional, Krupa, M., additional, Palczewski, P., additional, Pruszczyk, P., additional, De Sousa, C. C., additional, Vigario, A., additional, Pinho, T., additional, Silva Cardoso, J., additional, Park, S.-J., additional, Song, J.-E., additional, Lee, Y.-J., additional, Ha, M.-R., additional, Chang, S.-A., additional, Choi, J.-O., additional, Lee, S.-C., additional, Park, S., additional, Oh, J., additional, Van De Bruaene, A., additional, De Meester, P., additional, Buys, R., additional, Vanhees, L., additional, Delcroix, M., additional, Voigt, J., additional, Budts, W., additional, Blundo, A., additional, Buccheri, S., additional, Monte, I. P., additional, Leggio, S., additional, Tamburino, C., additional, Sotaquira, M., additional, Lang, R., additional, Caiani, E., additional, Floria, M., additional, De Roy, L., additional, Xhaet, O., additional, Blommaert, D., additional, Jamart, J., additional, Gerard, M., additional, Deceuninck, O., additional, Marchandise, B., additional, Seldrum, S., additional, Schroeder, E., additional, Unsworth, B., additional, Sohaib, S., additional, Kulwant-Kaur, K., additional, Malcolme-Lawes, L., additional, Kanagaratnam, P., additional, Malik, I., additional, Ren, B., additional, Mulder, H., additional, Haak, A., additional, Van Stralen, M., additional, Szili-Torok, T., additional, Pluim, J., additional, Geleijnse, M., additional, Bosch, J., additional, Baglini, R., additional, Amaducci, A., additional, D'ancona, G., additional, Van Den Oord, S., additional, Akkus, Z., additional, Ten Kate, G., additional, Renaud, G., additional, Sijbrands, E., additional, De Jong, N., additional, Van Der Lugt, A., additional, Van Der Steen, A., additional, Schinkel, A., additional, Bjallmark, A., additional, Larsson, M., additional, Grishenkov, D., additional, Brodin, L.-A., additional, Brismar, T., additional, Paradossi, G., additional, Sveen, K. A., additional, Nerdrum, T., additional, Hanssen, K., additional, Dahl-Jorgensen, K., additional, Steine, K., additional, Cimino, S., additional, Pedrizzetti, G., additional, Tonti, G., additional, Canali, E., additional, Petronilli, V., additional, Cicogna, F., additional, Arcari, L., additional, De Luca, L., additional, Iacoboni, C., additional, Agati, L., additional, Abdel Moneim, S. S., additional, Eifert Rain, S., additional, Bernier, M., additional, Bhat, G., additional, Hagen, M., additional, Bott-Kitslaar, D., additional, Castello, R., additional, Wilansky, S., additional, Pellikka, P., additional, Mulvagh, S., additional, Delithanasis, I., additional, Celutkiene, J., additional, Kenny, C., additional, Monaghan, M., additional, Park, W., additional, Hong, G., additional, Son, J., additional, Lee, S., additional, Kim, U., additional, Park, J., additional, Shin, D., additional, Kim, Y., additional, Toutouzas, K., additional, Drakopoulou, M., additional, Aggeli, C., additional, Felekos, I., additional, Nikolaou, C., additional, Synetos, A., additional, Stathogiannis, K., additional, Tsiamis, E., additional, Siores, E., additional, Stefanadis, C., additional, Plicht, B., additional, Kahlert, P., additional, Grave, T., additional, Buck, T., additional, Konorza, T., additional, Gursoy, M., additional, Gokdeniz, T., additional, Astarcioglu, M., additional, Bayram, Z., additional, Cakal, B., additional, Karakoyun, S., additional, Kalcik, M., additional, Acar, R., additional, Kahveci, G., additional, Ozkan, M., additional, Tsang, W., additional, Weinert, L., additional, Yurdakul, S., additional, Avci, B., additional, Sahin, S., additional, Dilekci, B., additional, Aytekin, S., additional, Arenga, F., additional, Hascoet, S., additional, Martin, R., additional, Dulac, Y., additional, Peyre, M., additional, Benzouid, C., additional, Hadeed, K., additional, Acar, P., additional, Zakarkaite, D., additional, Skorniakov, V., additional, Zvironaite, V., additional, Grabauskiene, V., additional, Burca, J., additional, Ciparyte, L., additional, Laucevicius, A., additional, Di Salvo, G., additional, Rea, A., additional, D'aiello, A., additional, Del Gaizo, F., additional, Pergola, V., additional, D'andrea, A., additional, Pacileo, G., additional, Calabro, R., additional, Russo, M., additional, Dedobbeleer, C., additional, Hadefi, A., additional, Naeije, R., additional, Unger, P., additional, Mornos, C., additional, Cozma, D., additional, Ionac, A., additional, Mornos, A., additional, Valcovici, M., additional, Pescariu, S., additional, Petrescu, L., additional, Hu, K., additional, Liu, D., additional, Niemann, M., additional, Herrmann, S., additional, Cikes, M., additional, Stoerk, S., additional, Knop, S., additional, Ertl, G., additional, Bijnens, B., additional, Weidemann, F., additional, De Knegt, M., additional, Biering-Sorensen, T., additional, Sogaard, P., additional, Sivertsen, J., additional, Jensen, J., additional, Mogelvang, R., additional, Lam, W., additional, Tang, M., additional, Chan, K., additional, Yang, Y., additional, Fang, F., additional, Sun, J., additional, Yu, C., additional, Lam, Y., additional, Panoulas, V., additional, Sulemane, S., additional, Bratsas, A., additional, Konstantinou, K., additional, Francone, M., additional, Schau, T., additional, Seifert, M., additional, Ridjab, D., additional, Schoep, M., additional, Gottwald, M., additional, Neuss, M., additional, Meyhoefer, J., additional, Zaenker, M., additional, Butter, C., additional, Tarr, A., additional, Stoebe, S., additional, Pfeiffer, D., additional, Hagendorff, A., additional, Maret, E., additional, Ahlander, B.-M., additional, Bjorklund, P.-G., additional, Engvall, J., additional, Staskiewicz, G., additional, Czekajska-Chehab, E., additional, Adamczyk, P., additional, Siek, E., additional, Przybylski, P., additional, Maciejewski, R., additional, Drop, A., additional, Jimenez Rubio, C., additional, Isasti Aizpurua, G., additional, Miralles Ibarra, J., additional, Al-Mallah, M., additional, Somg, T., additional, Alam, S., additional, Chattahi, J., additional, Zweig, B., additional, Dhanalakota, K., additional, Boedeker, S., additional, Ananthasubramaniam, K., additional, Park, C., additional, March, K., additional, Jones, S., additional, Mayet, J., additional, Tillin, T., additional, Chaturvedi, N., additional, Hughes, A., additional, Hamodraka, E., additional, Kallistratos, E., additional, Karamanou, A., additional, Tsoukas, T., additional, Mavropoulos, D., additional, Kouremenos, N., additional, Zaharopoulou, I., additional, Nikolaidis, N., additional, Kremastinos, D., additional, Manolis, A., additional, Loboz-Rudnicka, M., additional, Jaroch, J., additional, Bociaga, Z., additional, Kruszynska, E., additional, Ciecierzynska, B., additional, Dziuba, M., additional, Dudek, K., additional, Uchmanowicz, I., additional, Loboz-Grudzien, K., additional, Silva, D., additional, Magalhaes, A., additional, Jorge, C., additional, Cortez-Dias, N., additional, Carrilho-Ferreira, P., additional, Silva Marques, J., additional, Portela, I., additional, Pascoa, C., additional, Nunes Diogo, A., additional, Brito, D., additional, Roosens, B., additional, Bala, G., additional, Droogmans, S., additional, Hostens, J., additional, Somja, J., additional, Delvenne, E., additional, Schiettecatte, J., additional, Lahoutte, T., additional, Van Camp, G., additional, and Cosyns, B., additional

Published
2012
Full Text
View/download PDF

12. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023).

Author

Bastante T, Arzamendi D, Martín-Moreiras J, Cid Álvarez AB, Carballo Garrido J, Andraka L, Gómez Jaume A, Merino Otermin Á, Artáiz Urdaci M, Ruiz Salmerón R, Pérez de Prado A, Cruz González I, Calviño Santos R, Bayón J, Trillo R, Antonio Baz J, Berenguer A, Casanova Sandoval JM, Álvarez Antón S, Sabaté M, Ruiz Nodar JM, Valero Picher E, Amat Santos IJ, Ruiz Arroyo JR, Pinar Bermúdez E, Íñigo-García LA, Arzamendi D, Jerez Valero M, Cerrato García P, Bosch Peligero E, Vaquerizo Montilla B, Subinas Elorriaga A, Sánchez Pérez I, Jiménez Mazuecos FJ, Tejada Ponce D, Santos Martínez S, Moreu J, Elízaga J, Cascón Pérez JD, García E, Mainar V, Ávila González MDM, Vergara R, Macaya C, Rasines Rodríguez A, Fernández-Ortiz A, Ojeda Pineda S, Bethencourt González A, Palazuelos J, López Palop R, Alegría Barrero E, Camacho Freire SJ, Portero Pérez MP, Peña Perez G, Vázquez Álvarez ME, Roura G, Agudelo V, Freixa X, Carrillo X, Mohandes M, Muñoz Camacho JF, Millán R, García Del Blanco B, Sarnago F, Torres Bosco A, Sáez R, Avanzas P, Pérez Vizcayno MJ, Caballero Borrego J, Blanco Mata R, Merchán Herrera A, Luengo Mondéjar P, Lozano Í, Portales Fernández J, Bosa Ojeda F, Martín Lorenzo P, Novo García E, Fernández Guerrero JC, González Caballero E, Rivero F, Pomar F, Ruiz Quevedo V, Morales Ponce FJ, Ruiz García J, Romero Vazquiánez M, Tellería M, Baello Monge P, Botas Rodríguez J, Franco Peláez JA, Unzue L, Gómez Menchero AE, Sánchez Recalde Á, Jurado Román A, Sainz Laso F, Fuertes Ferre G, Pimienta González R, Oteo Domínguez JF, Gutiérrez A, Bullones Ramírez JA, Sánchez-Aquino González R, Frutos Garcia A, Fajardo Molina R, Núñez Pernas D, Alonso Briales JH, Sánchez Gila J, Sánchez Burguillos FJ, Guisado Rasco A, Vizcaino Arellano M, Díez Gil JL, de la Borbolla Fernández RG, Ramírez A, and Larman M

Subjects
Spain, Humans, Registries, Cardiac Catheterization methods, Cardiac Catheterization statistics & numerical data, Societies, Medical, Percutaneous Coronary Intervention methods, Percutaneous Coronary Intervention statistics & numerical data, Cardiology
Abstract

Introduction and Objectives: This article presents the 2023 activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC)., Methods: All interventional cardiology laboratories in Spain were invited to participate in an online survey. Data analysis was carried out by an external company and subsequently reviewed and presented by the members of the ACI-SEC board., Results: A total of 119 hospitals participated. The number of diagnostic studies decreased by 1.8%, while the number of percutaneous coronary interventions (PCI) showed a slight increase. There was a reduction in the number of stents used and an increase in the use of drug-coated balloons. The use of intracoronary diagnostic techniques remained stable. For the first time, data on PCI guided by intracoronary imaging was reported, showing a 10% usage rate in Spain. Techniques for plaque modification continued to grow. Primary PCI increased, becoming the predominant treatment for myocardial infarction (97%). Noncoronary structural procedures continued their upward trend. Notably, the number of left atrial appendage closures, patent foramen ovale closures, and tricuspid valve interventions grew in 2023. There was also a significant increase in interventions for acute pulmonary embolism., Conclusions: The 2023 Spanish cardiac catheterization and coronary intervention registry indicates a stabilization in coronary interventions, together with an increase in complexity. There was consistent growth in procedures for both valvular and nonvalvular structural heart diseases., (Copyright © 2024 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)

Published
2024
Full Text
View/download PDF

13. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022).

Author

Jurado-Román A, Freixa X, Cid B, Cruz-González I, Sarnago Cebada F, Baz JA, Lozano Í, Sabaté M, Jiménez J, Íñigo García LA, Subinas Elorriaga A, Berenguer Jofresa A, Novo García E, Pérez Vizcayno MJ, Carrillo Suárez X, Pinar Bermúdez E, Calviño Santos R, Álvarez Antón S, Trillo Nouche R, Ruíz Arroyo JR, Fernández Cisnal A, Amat-Santos IJ, Jerez Valero M, Rama Merchán JC, Vaquerizo B, Tejada Ponce D, Ruiz Nodar JM, Sánchez Pérez I, Tejedor P, Elizaga J, Jiménez Cabrera FM, Bullones Ramírez JA, Sánchez Aquino R, Portero Pérez MP, Roura G, Mohandes M, Sáez Moreno R, Avanzas P, Caballero J, Torres Bosco AM, Merchán Herrera A, Robles Alonso J, Bosa Ojeda F, García San Román K, Agudelo VH, Martin Lorenzo P, Fernández JC, Pérez de Prado A, Ruiz Quevedo V, Cruz González I, Moreu Burgos J, Ruiz García J, Sánchez Burguillos FJ, Núñez Pernas D, Baello Monge P, Hernando Marrupe L, Franco Peláez JA, Jurado Román A, Pomar Domingo F, Fuertes Ferre G, Pimienta González R, Morales Ponce FJ, Sánchez Recalde Á, Ojeda Pineda S, Frutos Garcia A, Millán Segovia R, Fajardo Molina R, Díez Gil JL, Guisado Rasco A, Gómez Menchero AE, Bosch E, Oteo Domínguez JF, Gutiérrez-Barrios A, Cascón Pérez JD, Casanova Sandoval JM, Fernández Portales J, Rivero Crespo F, Gonzalez Caballero E, Ocaranza Sánchez R, Zueco J, García Del Blanco B, Alonso Briales JH, Sánchez Gila J, Vizcaino Arellano M, Carballo Garrido J, Andraka L, Gómez Jaume A, Merino Otermin Á, Artaiz Urdaci M, Arellano Serrano C, Íñigo García LA, García E, Unzué L, Ruiz Nodar JM, Arzamendi D, Freixa X, Mainar V, Usón M, Palazuelos Molinero J, López Palop R, Bethencourt A, Alegría Barrero E, Camacho Freire SJ, Peña G, Vázquez Álvarez ME, Muñoz Camacho JF, Ramírez Moreno A, Larman Tellechea M, and García de la Borbolla Fernández R

Subjects
Humans, Cardiac Catheterization, Registries, Percutaneous Coronary Intervention, Coronary Artery Disease, Cardiology
Abstract

Introduction and Objectives: This article presents the annual activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) for the year 2022., Methods: All Spanish centers with catheterization laboratories were invited to participate. Data were collected online and were analyzed by an external company in collaboration with the members of the board of the ACI-SEC., Results: A total of 111 centers participated. The number of diagnostic studies increased by 4.8% compared with 2021, while that of percutaneous coronary interventions (PCI) remained stable. PCIs on the left main coronary artery increased by 22%. The radial approach continued to be preferred for PCI (94.9%). There was an upsurge in the use of drug-eluting balloons, as well as in intracoronary imaging techniques, which were used in 14.7% of PCIs. The use of pressure wires also increased (6.3% vs 2021) as did plaque modification techniques. Primary PCI continued to grow and was the most frequent treatment (97%) in ST-segment elevation myocardial infarction. Most noncoronary procedures maintained their upward trend, particularly percutaneous aortic valve implantation, atrial appendage closure, mitral/tricuspid edge-to-edge therapy, renal denervation, and percutaneous treatment of pulmonary arterial disease., Conclusions: The Spanish cardiac catheterization and coronary intervention registry for 2022 reveals a rise in the complexity of coronary disease, along with a notable growth in procedures for valvular and nonvalvular structural heart disease., (Copyright © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)

Published
2023
Full Text
View/download PDF

14. Prosthesis-patient mismatch after transcatheter aortic valve replacement: prevalence and medium term prognostic impact.

Author

León Del Pino MDC, Ruíz Ortiz M, Delgado Ortega M, Sánchez Fernández J, Ferreiro Quero C, Durán Jiménez E, Romero Moreno M, Segura Saint-Gerons J, Ojeda Pineda S, Pan Álvarez-Ossorio M, and Mesa Rubio D

Subjects
Aged, Aged, 80 and over, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis mortality, Aortic Valve Stenosis physiopathology, Echocardiography, Female, Humans, Incidence, Male, Postoperative Complications diagnostic imaging, Postoperative Complications mortality, Postoperative Complications physiopathology, Prevalence, Progression-Free Survival, Prosthesis Design, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Spain epidemiology, Time Factors, Transcatheter Aortic Valve Replacement mortality, Treatment Outcome, Aortic Valve surgery, Aortic Valve Stenosis surgery, Heart Valve Prosthesis, Postoperative Complications epidemiology, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation
Abstract

Prosthesis-patient mismatch (PPM) occurs when the effective orifice area of the prosthesis is too small in relation to the patient's body surface area. There are few data available on the frequency and prognostic impact of PPM after transcatheter aortic valve implantation (TAVI). Our aim was to determine the prevalence of PPM and to investigate its association with medium-term clinical course of patients undergoing TAVI. We included 185 patients undergoing TAVI (79 ± 5 years, 49% male, 98% CoreValve) between April-2008 and December-2014. The effective orifice area (EOA) was determined by transthoracic echocardiography prior and after the procedure. We defined PPM as indexed EOA ≤ 0.85 cm 2 /m 2 (severe PPM if ≤ 0.65 cm 2 /m 2 ). All cause death, stroke and hospitalization for heart failure were considered as major clinical events. 45 patients (24%) showed PPM (severe 11 patients, 6%). PPM was associated with a higher EuroSCORE (OR 1.06, IC 95% 1.01-1.12, p = 0.03), body surface area ≥ 1.72 m 2 (OR 3.58, IC 95% 1.30-9.87, p = 0.01) and small aortic annulus (OR 0.73, IC 95% 0.55-0.92, p = 0.03); and severe PPM with small prostheses size (OR 17.79, IC 95% 1.87-169.78, p = 0.012). The mean event-free survival was 34 ± 26 months. Patients with severe PPM showed lower rates of event free survival than the rest of the series (52% vs. 84%, p = 0.04) at 34 months follow up. In our series, PPM was present in a quarter of the patients after TAVI. Higher EuroSCORE, smaller prosthesis size, larger body surface area and smaller aortic annulus diameter were associated with PPM. Severe PPM was an independent factor associated with major events at medium-term follow up.

Published
2019
Full Text
View/download PDF

15. Criteria for the Management of Technological Assets in Cardiovascular Imaging.

Author

Fernández Lozano I, Pozo Osinalde E, García Bolao I, Ojeda Pineda S, Rodríguez Padial L, and Íñiguez Romo A

Subjects
Cardiac Imaging Techniques economics, Diagnostic Imaging economics, Humans, Spain, Cardiac Imaging Techniques statistics & numerical data, Cardiology, Diagnostic Imaging statistics & numerical data, Hospital Design and Construction
Abstract

Adequate, updated and functional technology is essential in cardiology. In Spain, the economic scenario has strongly impacted technology renewal programs and obsolescence is a growing problem. The current report attempts to describe the current situation and the conditions that must concur to update, replace or adopt new technologies in the field of cardiology., (Copyright © 2018 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)

Published
2018
Full Text
View/download PDF

16. Long-term clinical impact of permanent cardiac pacing after transcatheter aortic valve implantation with the CoreValve prosthesis: a single center experience.

Author

López-Aguilera J, Segura Saint-Gerons JM, Sánchez Fernández J, Mazuelos Bellido F, Pan Álvarez-Ossorio M, Suárez de Lezo J, Romero Moreno M, Ojeda Pineda S, Pavlovic D, Mesa Rubio D, Rodriguez Diego S, Ferreiro C, Durán E, Chavarría J, Moya González J, and Suárez de Lezo J

Subjects
Aged, Aged, 80 and over, Cardiac Catheterization methods, Female, Humans, Male, Outcome and Process Assessment, Health Care, Patient Readmission statistics & numerical data, Prosthesis Design, Risk Adjustment methods, Spain epidemiology, Time, Aortic Valve, Aortic Valve Stenosis diagnosis, Aortic Valve Stenosis mortality, Aortic Valve Stenosis surgery, Cardiac Pacing, Artificial methods, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation, Transcatheter Aortic Valve Replacement methods
Abstract

Aims: To determine the impact of permanent cardiac pacing after transcatheter aortic valve implantation (TAVI) with the CoreValveTM prosthesis in terms of all-cause mortality and morbidity [rehospitalizations for heart failure (HF) or stroke] at the long-term follow-up., Methods and Results: The prospective analysis comprised 259 patients (138 women, 53.3%, age 78 ± 6 years) treated by a CoreValveTM prosthesis from April 2008 to December 2015. Forty-two patients were excluded for analysis: 9 with pre-existing permanent pacemaker (PPM) implantation, 19 who required a PPM during the follow-up and 14 patients because of hospital mortality during or after the CoreValveTM prosthesis implantation procedure. The remaining 217 patients were divided in two groups: Group-1 included those patients who required a PPM immediately after TAVI, and Group-2 included those patients who did not require permanent cardiac pacing at the long-term follow-up. Patients received follow-up at 1-month, 6-months, 12-months, and yearly thereafter. A total of 39 patients required a PPM immediately after TAVI (15.0%), but 178 patients (68.7%) did not. The mean follow-up was 37 ± 27 months (range 3-99 months) in both groups. There was no difference between the two groups in terms of all-cause mortality (52.6% vs. 56.8%, P = 0.125; HR 1.22 [0.87-1.77, 95% CI]), or stroke (13.3% vs. 15.1% P = 0.842; HR 1.12 [0.37-3.32, 95% CI]). However, patients who underwent PPM implantation developed an increase in readmissions for HF (21.1% vs. 31.9%, P = 0.015; HR 1.82 [1.23-3.92, 95% CI])., Conclusion: Patients requiring a PPM after TAVI did not have an increase in mortality, or an increase in the likelihood of developing a stroke at a long-term follow-up. However, this subgroup of patients showed an increase in rehospitalization due to HF at medium- and long-term follow-up.

Published
2018
Full Text
View/download PDF

17. Atrioventricular Conduction Changes After CoreValve Transcatheter Aortic Valve Implantation.

Author

López-Aguilera J, Segura Saint-Gerons JM, Mazuelos Bellido F, Suárez de Lezo J, Ojeda Pineda S, Pan Álvarez-Ossorio M, Romero Moreno MÁ, Pavlovic D, Espejo Pérez S, and Suárez de Lezo J

Subjects
Aged, Aortic Valve diagnostic imaging, Aortic Valve Stenosis diagnosis, Bundle-Branch Block physiopathology, Bundle-Branch Block therapy, Echocardiography, Electrocardiography, Female, Follow-Up Studies, Humans, Incidence, Male, Pacemaker, Artificial, Prognosis, Retrospective Studies, Severity of Illness Index, Tomography, X-Ray Computed, Treatment Outcome, Aortic Valve surgery, Aortic Valve Stenosis surgery, Bundle-Branch Block etiology, Heart Valve Prosthesis adverse effects, Transcatheter Aortic Valve Replacement adverse effects
Abstract

Introduction and Objectives: Conduction disturbances often occur after CoreValve transcatheter aortic valve implantation. The aim was to analyze which cardiac conduction changes occur in patients with aortic stenosis treated with this type of prosthesis., Methods: A total of 181 patients with severe aortic stenosis treated with this prosthesis and studied by electrocardiography between April 2008 and December 2013 were selected. A subgroup of 137 (75.7%) consecutive patients was studied by intracardiac electrocardiogram before and after prosthesis implantation. The primary endpoint of the study was the need for a permanent pacemaker within 72 hours after prosthesis implantation. Numerous variables to predict this possibility were analyzed., Results: Following implantation, PR and QRS intervals were increased from 173±47 ms to 190±52ms (P < .01) and from 98±22ms to 129±24 ms (P < .01), whereas the A-H and H-V intervals were prolonged from 95±39ms to 108±41ms (P < .01) and from 54±10ms to 66±23ms (P < .01). A total of 89 (49%) patients had new-onset left bundle-branch block, and 33 (25%) required a pacemaker within the first 72hours. The independent predictors for a pacemaker were baseline right bundle-branch block and prosthetic depth. Intracardiac intervals had no predictive value. In addition, 13 patients required a pacemaker after 72 hours., Conclusions: CoreValve prosthesis implantation has a high incidence of conduction disturbance, with left bundle-branch block being the most common. A total of 25% of patients required a permanent pacemaker. The need for a pacemaker was related to baseline right bundle-branch block and prosthetic depth., (Copyright © 2015 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)

Published
2016
Full Text
View/download PDF

18. Idiopathic Dilated Cardiomyopathy Treated With Intracoronary Infusion of Autologous Bone Marrow Cells: Long-term Follow-up.

Author

Baeza Garzón F, Romero M, Suárez de Lezo J, Ojeda Pineda S, Herrera C, and Suárez de Lezo J

Subjects
Coronary Vessels, Female, Follow-Up Studies, Humans, Infusions, Intra-Arterial, Male, Middle Aged, Time Factors, Transplantation, Autologous, Treatment Outcome, Bone Marrow Cells cytology, Bone Marrow Transplantation methods, Cardiomyopathy, Dilated therapy
Published
2015
Full Text
View/download PDF

19. Measurement of aortic valve annulus using different cardiac imaging techniques in transcatheter aortic valve implantation: agreement with finally implanted prosthesis size.

Author

Mesa Rubio D, Suárez de Lezo Cruz Conde J, Alvarez-Osorio MP, Ruiz Ortiz M, Delgado Ortega M, León del Pino Mdel C, Toledano Delgado F, Segura Saint-Gerons J, Ojeda Pineda S, Garcia Fuertes D, Crespín Crespín M, Espejo S, and Ysamat R

Subjects
Aged, Aged, 80 and over, Coronary Angiography methods, Echocardiography methods, Female, Humans, Male, Predictive Value of Tests, Prosthesis Design, Tomography, X-Ray Computed methods, Treatment Outcome, Aortic Valve diagnostic imaging, Aortic Valve surgery, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation methods
Abstract

Aims: To compare the measurements of the aortic annulus obtained with various imaging techniques in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation, and to determine the grade of agreement between the predicted size of the prosthesis for each technique, and the size of the finally implanted valve., Methods and Results: The aortic annulus was measured in 40 patients treated by transcatheter aortic valve implantation (CoreValve aortic valve) with transthoracic (TTE) and transesophageal echocardiography (TEE), 64-slice tomography, and angiography. A large valve was implanted when annulus was >23 mm and a small one if it was ≤23 mm. If the size of the prosthesis predicted by several techniques was not the same in one case, we selected the size in which more techniques presented agreement. Forty aortic valves, 26 small and 14 large, were implanted percutaneously. The best correlation was obtained with TTE and TEE (r = 0.93, P < 0.001). The correlation of TTE and TEE with angiography also was good (r = 0.58, P < 0.001 and r = 0.53, P < 0.001, respectively). Correlations between these techniques and computed tomography were poor (P = NS for all comparisons). The best agreement between estimated aortic annulus and implanted valve size was obtained with transtoracic and TEE (κ= 0.88 and 0.76)., Conclusions: The aortic annulus measurements obtained by TTE, TEE, and angiography correlated well, while tomography correlated poorly with other techniques. The imaging techniques that showed the best agreement between estimated aortic annulus size and implanted aortic valve size were TTE and TEE., (© 2011, Wiley Periodicals, Inc.)

Published
2011
Full Text
View/download PDF

20. [Medical treatment of heart failure with preserved left ventricular ejection fraction].

Author

Anguita Sánchez M and Ojeda Pineda S

Subjects
Heart Failure diagnosis, Heart Failure physiopathology, Humans, Prognosis, Stroke Volume, Ventricular Function, Left physiology, Heart Failure drug therapy
Abstract

Diastolic heart failure (i.e., heart failure with preserved systolic function) accounts for 30%-50% of all cases of heart failure. Prognosis is almost as poor as with systolic heart failure. Currently, the only requirements for diagnosis are that strict clinical criteria for heart failure are satisfied and that the left ventricular ejection fraction is preserved (i.e., greater than 40%-50%), although in the future measurement of brain natriuretic peptides could be useful. Because of a lack of evidence from large clinical trials, with the exception of the CHARM study which showed that candesartan slightly reduced the hospital readmission rate, therapy is based on the identification and treatment of the causal condition (e.g., hypertension or coronary heart disease), heart rate control, and relief of congestion. Thus, combination treatment with low-dose diuretics, bradycardiac antihypertensives (e.g., beta-blockers or calcium antagonists), and angiotensin antagonists currently seems to be the best therapeutic approach.

Published
2006
Full Text
View/download PDF

21. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].

Author

Anguita Sánchez M, Rodríguez Esteban M, Ojeda Pineda S, Ruiz Ortiz M, Romo Peña E, Mesa Rubio D, and Vallés Belsué F

Subjects
Cardiomyopathy, Dilated complications, Cardiomyopathy, Dilated mortality, Female, Heart Failure complications, Heart Failure mortality, Humans, Hypertension complications, Hypertension mortality, Male, Middle Aged, Multivariate Analysis, Prognosis, Recovery of Function, Survival Analysis, Systole, Treatment Outcome, Ventricular Dysfunction, Left complications, Ventricular Dysfunction, Left mortality, Cardiomyopathy, Dilated drug therapy, Cardiovascular Agents therapeutic use, Heart Failure drug therapy, Hypertension drug therapy, Ventricular Dysfunction, Left drug therapy
Abstract

Introduction and Objectives: There is little information on the clinical and functional course of patients with heart failure secondary to dilated cardiomyopathy due to hypertension. The objectives of our study were to assess the clinical and functional course of these patients, and to identify possible predictors of prognosis., Patients and Method: We evaluated a series of 49 patients with this condition diagnosed in our hospital from 1994 to 2003. Mean age was 63(11) years, and 40% were women. Left ventricular ejection fraction was 30.1(4.8)%. Follow-up was 45(23) months (median, 41 months)., Results: Four-year survival was 0.84, the 4-year rate of hospitalization due to heart failure was 0.12, and likelihood of readmission-free survival was 0.80 at 4 years. Left ventricular ejection fraction increased from 30.1(4.8)% to 57.6(13.5)% (P< .001). An unfavorable clinical and functional outcome at 4 years (death, readmission for heart failure or persistence of dilated cardiomyopathy) was recorded in only in 40% of the patients. Multivariate analysis with the Cox model showed appropriate control of blood pressure to be the only independent predictor of a favorable clinical outcome (absence of death or readmission for heart failure) (hazard ratio = 4.58; 95% CI, 1.32-9.83; P=.032)., Conclusions: The course of patients with severe dilated cardiomyopathy due to hypertension was favorable in 60% of cases. Adequate control of blood pressure was the only independent predictor of a favorable clinical outcome.

Published
2004

22. [Diagnosis and therapy for diastolic heart failure].

Author

Anguita Sánchez M and Ojeda Pineda S

Subjects
Cardiovascular Agents therapeutic use, Clinical Trials as Topic, Diastole physiology, Heart Failure physiopathology, Humans, Prognosis, Ventricular Dysfunction, Left diagnosis, Ventricular Dysfunction, Left physiopathology, Heart Failure diagnosis, Heart Failure drug therapy
Abstract

Diastolic heart failure (heart failure with preserved systolic function) causes 30% to 50% of all cases of heart failure, and its prognosis is almost as ominous as that of systolic heart failure. Currently, it is diagnosed when clinical criteria for heart failure are present and left ventricular ejection fraction is preserved (higher than 40% to 50%). However, determinations of brain natriuretic peptides may play an important role in the future. Because we have no evidence from clinical trials, with the exception of the slight benefit obtained with candesartan in reducing hospitalizations in the CHARM Study, treatment of diastolic heart failure is based on the identification and treatment of the causal factor (hypertension, coronary heart disease), control of heart rate, and relief of fluid congestion. Thus, combined therapy with low-dose diuretics, antihypertensive drugs for bradycardia (beta blockers, calcium antagonists) and angiotensin antagonists seems now to be the best therapeutic strategy.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results